Approvals/TGA/SIFROL pramipexole dihydrochloride monohydrate 1.0 mg tablet blister pack

Approved

STANDARD

SIFROL pramipexole dihydrochloride monohydrate 1.0 mg tablet blister pack

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c2aa9d3ea927c7c1
Product Name: SIFROL pramipexole dihydrochloride monohydrate 1.0 mg tablet blister pack
Artg Id: 66485
Artg Name: SIFROL pramipexole dihydrochloride monohydrate 1.0 mg tablet blister pack
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 1999-04-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/20614bddaab8214ce5855198f5430c28.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d5e484834e19ec2a9764f84ec5d9b3d1.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

c2aa9d3ea927c7c1

Type

Standard